IQVIA Pharma Deals Half-Year Review of 2024
By Lucy Haggerty, Taskin Ahmed, Ayush Saxena & Swati Sharan
Pharma Deals Review: Vol 2024 Issue 9 (Table of Contents)
Published: 17 Sep-2024
DOI: 10.3833/pdr.v2024.i9.2900 ISSN: 1756-7874
Section: Opinion & Analysis
Fulltext:
Abstract
The slowdown in deal activity in the life sciences sector that was seen in 2023 continued in H1 2024 as persistent macroeconomic headwinds discouraged dealmakers from signing certain transactions that could be perceived as ‘risky’...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS